News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
667,012 Results
Type
Article (62459)
Company Profile (77)
Press Release (604467)
Multimedia
Podcasts (103)
Webinars (21)
Section
Business (174095)
Career Advice (2751)
Deals (32544)
Drug Delivery (117)
Drug Development (77119)
Employer Resources (154)
FDA (15168)
Job Trends (13950)
News (305880)
Policy (29131)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (2)
Academia (2913)
Academic (2)
Accelerated approval (35)
Adcomms (28)
Allergies (145)
Alliances (43263)
ALS (170)
Alzheimer's disease (1609)
Antibody-drug conjugate (ADC) (297)
Approvals (15449)
Artificial intelligence (540)
Autoimmune disease (168)
Automation (41)
Bankruptcy (291)
Best Places to Work (10854)
BIOSECURE Act (16)
Biosimilars (180)
Biotechnology (55)
Bladder cancer (158)
Brain cancer (61)
Breast cancer (633)
Cancer (4781)
Cardiovascular disease (399)
Career advice (2349)
Career pathing (40)
CAR-T (290)
CDC (48)
Celiac Disease (2)
Cell therapy (772)
Cervical cancer (36)
Clinical research (66114)
Collaboration (1676)
Company closure (5)
Compensation (729)
Complete response letters (59)
COVID-19 (2694)
CRISPR (97)
C-suite (925)
Cystic fibrosis (144)
Data (6227)
Decentralized trials (2)
Denatured (41)
Depression (138)
Diabetes (475)
Diagnostics (6490)
Digital health (45)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (251)
Drug pricing (185)
Drug shortages (25)
Duchenne muscular dystrophy (216)
Earnings (63372)
Editorial (60)
Employer branding (18)
Employer resources (138)
Events (98837)
Executive appointments (1046)
FDA (18324)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (9)
Frontotemporal dementia (23)
Funding (1474)
Gene editing (206)
Generative AI (46)
Gene therapy (578)
GLP-1 (913)
Government (4715)
Grass and pollen (7)
Guidances (381)
Healthcare (18266)
HIV (60)
Huntington's disease (40)
IgA nephropathy (80)
Immunology and inflammation (226)
Immuno-oncology (59)
Indications (113)
Infectious disease (2961)
Inflammatory bowel disease (194)
Inflation Reduction Act (13)
Influenza (118)
Intellectual property (252)
Interviews (531)
IPO (14932)
IRA (45)
Job creations (3420)
Job search strategy (1947)
JPM (62)
Kidney cancer (18)
Labor market (76)
Layoffs (592)
Leadership (37)
Legal (6474)
Liver cancer (84)
Longevity (13)
Lung cancer (635)
Lymphoma (369)
Machine learning (40)
Management (54)
Manufacturing (758)
MASH (165)
Medical device (13046)
Medtech (13100)
Mergers & acquisitions (18735)
Metabolic disorders (1217)
Multiple sclerosis (154)
NASH (13)
Neurodegenerative disease (311)
Neuropsychiatric disorders (88)
Neuroscience (2827)
Neurotech (1)
NextGen: Class of 2026 (6393)
Non-profit (4352)
Now hiring (21)
Obesity (553)
Opinion (296)
Ovarian cancer (162)
Pain (204)
Pancreatic cancer (229)
Parkinson's disease (279)
Partnered (33)
Patents (511)
Patient recruitment (517)
Peanut (59)
People (61288)
Pharmaceutical (19)
Pharmacy benefit managers (27)
Phase 1 (20842)
Phase 2 (29147)
Phase 3 (21273)
Pipeline (5348)
Policy (279)
Postmarket research (2470)
Preclinical (8852)
Press Release (67)
Prostate cancer (248)
Psychedelics (42)
Radiopharmaceuticals (282)
Rare diseases (841)
Real estate (6032)
Recruiting (66)
Regulatory (22371)
Reports (41)
Research institute (2469)
Resumes & cover letters (408)
Rett syndrome (28)
RNA editing (15)
RSV (72)
Schizophrenia (147)
Series A (244)
Series B (185)
Service/supplier (8)
Sickle cell disease (95)
Special edition (16)
Spinal muscular atrophy (155)
Sponsored (43)
Startups (3379)
State (1)
Stomach cancer (12)
Supply chain (87)
Tariffs (67)
The Weekly (59)
Vaccines (981)
Venture capital (78)
Weight loss (341)
Women's health (87)
Worklife (21)
Date
Today (169)
Last 7 days (658)
Last 30 days (2263)
Last 365 days (28393)
2026 (3983)
2025 (28684)
2024 (32284)
2023 (36336)
2022 (46630)
2021 (51588)
2020 (50740)
2019 (44768)
2018 (34055)
2017 (30707)
2016 (30056)
2015 (35433)
2014 (28371)
2013 (24947)
2012 (26205)
2011 (26447)
2010 (24925)
Location
Africa (886)
Alabama (86)
Alaska (6)
Arizona (241)
Arkansas (15)
Asia (39415)
Australia (7074)
California (10473)
Canada (3090)
China (1062)
Colorado (443)
Connecticut (462)
Delaware (331)
Europe (91957)
Florida (1586)
Georgia (352)
Hawaii (3)
Idaho (59)
Illinois (881)
India (68)
Indiana (484)
Iowa (22)
Japan (417)
Kansas (119)
Kentucky (39)
Louisiana (27)
Maine (75)
Maryland (1288)
Massachusetts (7381)
Michigan (337)
Minnesota (564)
Mississippi (6)
Missouri (138)
Montana (34)
Nebraska (26)
Nevada (114)
New Hampshire (77)
New Jersey (2911)
New Mexico (30)
New York (2854)
North Carolina (1421)
North Dakota (10)
Northern California (5062)
Ohio (324)
Oklahoma (23)
Oregon (42)
Pennsylvania (2065)
Puerto Rico (24)
Rhode Island (45)
South America (1187)
South Carolina (54)
South Dakota (1)
Southern California (4170)
Tennessee (170)
Texas (1672)
United States (37597)
Utah (326)
Vermont (1)
Virginia (260)
Washington D.C. (67)
Washington State (862)
West Virginia (4)
Wisconsin (125)
Wyoming (2)
667,012 Results for "university of marburg".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sabin Vaccine Institute’s Investigational Marburg Vaccine Delivered to Ethiopia for Outbreak Response
December 5, 2025
·
4 min read
Press Releases
Aptitude Secures $9M Partnership with BARDA to Develop Rapid Molecular Diagnostic for Ebolaviruses and Marburg Viruses
July 29, 2025
·
3 min read
FDA
FDA Grants Soligenix Orphan Drug Designation for the Prevention and Post-Exposure Prophylaxis Against Marburg Marburgvirus Infection
Soligenix, Inc. announced today that the Office of Orphan Products Development of the United States (U.S.) Food and Drug Administration (FDA) has granted orphan drug designation to the active ingredient in MarVax™, the subunit protein vaccine of recombinantly expressed Marburg marburgvirus (MARV) glycoprotein, for “the prevention and post-exposure prophylaxis against MARV infection.”
April 15, 2024
·
10 min read
Drug Development
Public Health Vaccines Announces Initiation of First Clinical Trial Evaluating Its Marburg Virus Vaccine
Public Health Vaccines, LLC (PHV) has started its Phase 1 clinical trial (NCT06265012) to evaluate the safety and immunogenicity of the company’s single-dose vaccine (PHV01) against Marburg virus - a hemorrhagic fever virus of the Filoviridae family that causes Marburg virus disease, a rare but severe hemorrhagic fever that affects people and non-human primates and has a case fatality rate of up to 88%.
March 21, 2024
·
2 min read
Drug Development
Sabin Vaccine Institute Begins Phase 2 Clinical Trial for Marburg Vaccine in Uganda
The Sabin Vaccine Institute has launched a Phase 2 clinical trial for its vaccine candidate against the lethal Marburg virus.
October 19, 2023
·
6 min read
Press Releases
OraSure Receives Federal Funding for Development of Marburg Virus Rapid Antigen Test
December 3, 2024
·
7 min read
Drug Development
Marburg vaccine tested at Texas Biomed moves to Phase 2 clinical trials
A Marburg virus vaccine tested at Texas Biomedical Research Institute (Texas Biomed) is progressing in clinical trials, moving a step closer towards becoming the world’s first vaccine against the deadly virus.
December 19, 2023
·
3 min read
Pharm Country
Soligenix Announces Publication Demonstrating Complete Protection Against Filovirus Disease in Nonhuman Primate Models of Ebola and Marburg Viruses
Soligenix, Inc. announced today a publication describing the preclinical efficacy of a novel, single-vial, bivalent vaccine providing 100% protection against both Sudan ebolavirus (SUDV) and Marburg marburgvirus (MARV) infections.
January 2, 2024
·
11 min read
Press Releases
First-of-its-kind Universal Clearance Establishes Maximum Regulatory Access to the Bezier Parametric Curve Spinal Rod System for Patients and Surgeons
February 5, 2026
·
2 min read
Business
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits
Virax Biolabs Group Limited announced today that it has entered into an agreement for the distribution of Marburg Virus PCR testing kits.
April 19, 2023
·
4 min read
1 of 66,702
Next